Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy

INTRODUCTION: Previous studies showed that high and low body mass index (BMI) was associated with worse prognosis in metastatic CRC (mCRC). Whether BMI is a prognostic or predictive factor in mCRC is unclear. We aimed to assess efficacy outcomes according to BMI in patient with metastatic colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales: Cybulska-Stopa, Bożena, Ługowska, Iwona, Wiśniowski, Rafał, Domagała-Haduch, Małgorzata, Rajczykowski, Marcin, Piejko, Karolina, Bar-Letkiewicz, Ilona, Suwiński, Rafał, Regulski, Krzysztof, Mackiewicz, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265962/
https://www.ncbi.nlm.nih.gov/pubmed/32514236
http://dx.doi.org/10.5114/wo.2020.94728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265962/
https://www.ncbi.nlm.nih.gov/pubmed/32514236
http://dx.doi.org/10.5114/wo.2020.94728

Ejemplares similares